A Resource for Healthcare and Social Services Professionals
May 17, 2022
5:00 pm–5:30 pm ET
The program will start with an introduction to HIV epidemiology and the connections to people who inject drugs. Then there will be a review of PrEP and PEP, safety, efficacy, and outcomes.
Via Zoom Webinar
The program will start with an introduction to HIV epidemiology and the connections to people who inject drugs. Then there will be a review of PrEP and PEP, safety, efficacy, and outcomes. The role of the pharmacist and pharmacy technician in the dispensing of these medications will be covered. There will also be a case presentation. Q&A will be encouraged throughout and the speaker will respond near the end of the presentation.
This activity is intended for pharmacists and pharmacy technicians working as part of the healthcare team to treat patients for substance use disorder.
PharmD, FAPhA
University of Rhode Island Clinical Professor of Pharmacy Practice
Dr. Jeffrey Bratberg is well acquainted with the challenges community pharmacists and pharmacies face regarding opioid dispensing, safety, overdose and addiction. In 2012, Bratberg, along with a University of Rhode Island student pharmacist, co-developed an overdose education and naloxone training program for pharmacists in the first-in-nation statewide Collaborative Pharmacy Practice Agreement for naloxone. He is an unpaid consultant for prescribetoprevent.org, a website devoted to opioid overdose education and naloxone training, which hosts an online continuing professional education program that has trained over 10,000 pharmacists nationwide. In 2015, he was selected to serve as a member of the Rhode Island Governor’s Overdose Prevention and Intervention Task Force. He is a consultant or co-investigator on federal grants from the National Institute on Drug Abuse, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality. Bratberg is the 2016 NASPA National Cardinal Health Generation Rx Award winner. The Generation Rx Champions Award honors a pharmacist who has demonstrated outstanding commitment to raising awareness of the dangers of Rx drug misuse among the general public, as well as the pharmacy community. Finally, Bratberg is the guest editor of the first ever special issue on Opioid Safety and Naloxone of the Journal of the American Pharmacists Association (Mar/April 2017).
Pharmacists Learning Objectives: At the completion of this activity, the participant will be able to:
1. Compare and contrast most recent guidelines for pre-exposure prophylaxis (PrEP) and Post-exposure prophylaxis (PEP)
2. Define the current role of the pharmacist regarding PrEP and PEP and potential role progression in the future
Pharmacy Technicians Learning Objectives: At the completion of this activity, the participant will be able to:
1. Compare and contrast most recent guidelines for pre-exposure prophylaxis (PrEP) and Post-exposure prophylaxis (PEP)
2. Define the current role of the pharmacy technician regarding PrEP and PEP and potential role progression in the future
Boston Medical Center Office-Based Addiction Treatment Training and Technical Assistance +, The Association for Multidisciplinary Education and Research in Substance Use and Addiction
Hosted on: Zoom Webinar
Topic Designator: Drug Therapy
Activity Type: Knowledge-based
Pharmacist | UAN 0026-9999-22-097-L01-P
Pharmacy Technician | UAN 0026-9999-22-097-L01-T
Accreditation
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 0.05 contact hours (0.05 CEUs).
Requirements for Credit
Attendance will be verified. Partial credit will not be awarded. Credit will not be issued to participants who join the meeting more than 7 minutes after the start of the meeting or to those who depart early. In order to receive credit you will need to complete the session evaluation within two weeks of attending the event.
Statement of Disclosure
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies, and that relevant conflicts of interest are mitigated. Speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.
Alyssa M. Peckham is employed by Otsuka Pharmaceutical Companies as a Neuroscience Medical Science Liaison.
Jeffery Bratberg holds no relevant financial relationship with ineligible companies.
OBAT TTA planning committee members have no relevant financial relationships with ineligible companies to disclose.
All MCPHS CE staff members have no relevant financial relationships with ineligible companies to disclose.
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.